ETFPanda

Amundi Smart Overnight Return UCITS ETF (Acc)

CSH2 · LU1190417599 · Euronext Paris
AmundiTracks Amundi Smart Overnight Return UCITS ETF (Acc) reference index
€1046.20
+0.29% today
60 sessions · price data is free, always
ISIN
LU1190417599
Ticker
CSH2
Theme
Money Market
TER
0.05%
Fund size
€4.5B
Replication
Synthetic
Distribution
Acc
Currency
EUR
Inception
2015

Liquidity & flows

PRO
Avg. daily volume
Avg. bid–ask spread
1M fund flows
Holdings
1
Unlock full data
Advertisement · 300×250300 × 250 · your banner here
Advertisement970 × 250 billboard

Reach European index investors at the moment they compare funds.

This billboard is available on the CSH2 fund page. Brokers, issuers and fintechs — your message sits directly above the screener our readers use to pick their next ETF.

Sponsored

Your product, in the feed our readers actually scan.

580 × 120 in-feed · native in-feed slot

Book this space

Fund profile

Sample reference data
Benchmark index
Amundi Smart Overnight Return UCITS ETF (Acc) reference index
Index provider
Multiple providers
Replication
Synthetic — unfunded swap with multiple counterparties, collateralised daily
Rebalancing
Quarterly
Securities lending
Not used
Legal structure
Open-ended SICAV sub-fund
Domicile
Luxembourg
UCITS
Yes — UCITS V compliant
SFDR classification
Article 9 — sustainable investment objective
Income treatment
Accumulating — income reinvested inside the fund
Distribution frequency
None — reinvested
Currency hedging
No — unhedged, currency risk is carried by the investor
Withholding tax
30% US withholding unless swap-based, no Luxembourg withholding on payouts
UK reporting status
Yes
Savings plans
Available at most German and Austrian brokers
Share class launch
September 2015
Fiscal year end
31 March
Depositary / custodian
Citibank Europe plc

Listings & identifiers

Sample cross-listings
WKN
4CQ7RR
SEDOL
0Z5SEEV
Valoren
7593400
Bloomberg
CSH2 NA
ExchangeTickerTrading currencyListing
Euronext ParisCSH2EURPrimary
Euronext AmsterdamCSH2EURCross-listing
XetraCSH2EURCross-listing

Top holdings

Top 10 = 44.3% of the fund · sample data
  1. 1ASML7.66%
  2. 2Novo Nordisk6.67%
  3. 3Nestlé5.80%
  4. 4SAP5.05%
  5. 5LVMH4.39%
  6. 6AstraZeneca3.82%
  7. 7Roche3.32%
  8. 8Shell2.89%
  9. 9Siemens2.51%
  10. 10Novartis2.19%

1 positions in total — the remaining 55.7% sits in the long tail.

Risk, return & total cost

Sample figures — not investment advice
SRRI risk score
3 of 7
3Y volatility
20.3%
Max drawdown
−34.2%

Performance history

PRO
1Y total return
3Y annualised
Tracking difference
Sharpe ratio

What you actually pay each year

Ongoing charge (TER)
0.05%
Portfolio transaction costs
0.03%
of which index licence fee
0.02%
Estimated total cost
0.08%

Excludes your broker's commission and the bid–ask spread you pay on the way in and out.

Advertisement300 × 600 half-page

Sticky placement — stays in view while readers scroll.

Book this space
Advertisement · 728×90728 × 90 · your banner here
Advertisement970 × 250 footer billboard

Reach European index investors at the moment they compare funds.

This billboard is available on the foot of every fund page. Brokers, issuers and fintechs — your message sits directly above the screener our readers use to pick their next ETF.

Advertisement